Total Funding
59
59
Total FundingPost-IPO Equity raised
Growth Score
-20 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29106
Penumbra develops and manufactures medical devices used in interventional procedures for neurovascular and vascular conditions.
Acquired by 
Boston Scientific
- Shruthi Narayan: President, Interventional
Srini Conjeevaram: Vice President Corporate StrategyPast Role: Derma Sciences, Director
About the Company
Penumbra designs, develops, manufactures and markets medical devices for interventional therapies addressing neurovascular and vascular conditions. The company’s product range includes mechanical thrombectomy systems, peripheral thrombectomy tools, access catheters, embolization devices and neurosurgical tools used by healthcare providers and
hospitals globally. Its offerings support procedures such as clot removal in acute ischemic stroke, vascular embolization and other minimally invasive interventions. Penumbra sells through direct sales teams and distributor networks, and provides clinical support to practitioners integrating its technologies into treatment workflows.
Women Founded
